Literature DB >> 22178010

[Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document].

Jesús Rodríguez-Baño1, José Ramón Paño-Pardo, Luis Alvarez-Rocha, Angel Asensio, Esther Calbo, Emilia Cercenado, José Miguel Cisneros, Javier Cobo, Olga Delgado, José Garnacho-Montero, Santiago Grau, Juan Pablo Horcajada, Ana Hornero, Javier Murillas-Angoiti, Antonio Oliver, Belén Padilla, Juan Pasquau, Miquel Pujol, Patricia Ruiz-Garbajosa, Rafael San Juan, Rafael Sierra.   

Abstract

The antimicrobial agents are unique drugs for several reasons. First, their efficacy is higher than other drugs in terms of reduction of morbidity and mortality. Also, antibiotics are the only group of drugs associated with ecological effects, because their administration may contribute to the emergence and spread of microbial resistance. Finally, they are used by almost all medical specialties. Appropriate use of antimicrobials is very complex because of the important advances in the management of infectious diseases and the spread of antibiotic resistance. Thus, the implementation of programs for optimizing the use of antibiotics in hospitals (called PROA in this document) is necessary. This consensus document defines the objectives of the PROA (namely, to improve the clinical results of patients with infections, to minimise the adverse events associated to the use of antimicrobials including the emergence and spread of antibiotic resistance, and to ensure the use of the most cost-efficacious treatments), and provides recommendations for the implementation of these programs in Spanish hospitals. The key aspects of the recommendations are as follows. Multidisciplinary antibiotic teams should be formed, under the auspices of the Infection Committees. The PROA need to be considered as part of institutional programs and the strategic objectives of the hospital. The PROA should include specific objectives based on measurable indicators, and activities aimed at improving the use of antimicrobials, mainly through educational activities and interventions based more on training activities directed to prescribers than just on restrictive measures.
Copyright © 2011 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178010     DOI: 10.1016/j.eimc.2011.09.018

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  27 in total

1.  Assessment of Quality Indicators for Appropriate Antibiotic Use.

Authors:  Paula Arcenillas; Lucía Boix-Palop; Lucía Gómez; Mariona Xercavins; Pablo March; Laura Martinez; Montserrat Riera; Rosa Madridejos; Cristina Badia; Jordi Nicolás; Esther Calbo
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

2.  Antimicrobial stewardship in Spain: Programs for Optimizing the use of Antibiotics (PROA) in Spanish hospitals.

Authors:  Juan P Horcajada; Santiago Grau; José Ramón Paño-Pardo; Antonio López; Antonio Oliver; José M Cisneros; Jesús Rodriguez-Baño
Journal:  Germs       Date:  2018-09-03

3.  The impact of an antimicrobial stewardship programme on the use of antimicrobials and the evolution of drug resistance.

Authors:  A Del Arco; B Tortajada; J de la Torre; J Olalla; J L Prada; F Fernández; F Rivas; J García-Alegría; V Faus; N Montiel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-16       Impact factor: 3.267

4.  Does the use of new cephalosporins follow the authorised, financed and approved indications? A study of their use in routine clinical practice in a tertiary hospital.

Authors:  Andrés Pintado-Álvarez; Lucia Yunquera-Romero; Ignacio Márquez-Gómez; Rocío Asensi-Díez
Journal:  Eur J Hosp Pharm       Date:  2021-12-21

5.  Antimicrobial Stewardship Improvement in Pediatric Intensive Care Units in Spain-What Have We Learned?

Authors:  Elena Fresán-Ruiz; Ana Carolina Izurieta-Pacheco; Mònica Girona-Alarcón; Juan Carlos de Carlos-Vicente; Amaya Bustinza-Arriortua; María Slocker-Barrio; Sylvia Belda-Hofheinz; Montserrat Nieto-Moro; Sonia María Uriona-Tuma; Laia Pinós-Tella; Elvira Morteruel-Arizcuren; Cristina Schuffelmann; Yolanda Peña-López; Sara Bobillo-Pérez; Iolanda Jordan
Journal:  Children (Basel)       Date:  2022-06-16

6.  A Before-and-After Study of the Effectiveness of an Antimicrobial Stewardship Program in Critical Care.

Authors:  Francisco Álvarez-Lerma; Santiago Grau; Daniel Echeverría-Esnal; Montserrat Martínez-Alonso; María Pilar Gracia-Arnillas; Juan Pablo Horcajada; Juan Ramón Masclans
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

7.  Evolution of Antimicrobial Consumption During the First Wave of COVID-19 Pandemic.

Authors:  Santiago Grau; Daniel Echeverria-Esnal; Silvia Gómez-Zorrilla; Maria Eugenia Navarrete-Rouco; Joan Ramon Masclans; Merce Espona; Maria Pilar Gracia-Arnillas; Xavier Duran; Merce Comas; Juan Pablo Horcajada; Olivia Ferrández
Journal:  Antibiotics (Basel)       Date:  2021-01-29

8.  Epidemiological aspects and prevalence study of nosocomial infections in a general hospital of specialties: retrospective analysis 2012-2017.

Authors:  Félix Gómez-De Rueda; Rafael Martinez-Nogueras; Maria Eugenia Tena-Sempere; Inmaculada Elosegui-Horno; Laura Robles-Rodríguez; Florentina Horno-Ureña
Journal:  Eur J Hosp Pharm       Date:  2018-06-19

9.  Implementation of a computerized decision support system to improve the appropriateness of antibiotic therapy using local microbiologic data.

Authors:  Manuel Rodriguez-Maresca; Antonio Sorlozano; Magnolia Grau; Rocio Rodriguez-Castaño; Andres Ruiz-Valverde; Jose Gutierrez-Fernandez
Journal:  Biomed Res Int       Date:  2014-08-17       Impact factor: 3.411

10.  Antimicrobial stewardship program at a tertiary care academic medical hospital: Clinical, microbiological and economic impact. A 5-year temporary descriptive study.

Authors:  Alfredo Jover-Sáenz; María Fernanda Ramírez-Hidalgo; Montserrat Vallverdú Vidal; Merce García González; Santiago Manuel Cano Marrón; Alfredo Escartín Arias; Miquel Falguera Sacrest; Dolors Castellana-Perelló; Fernando Barcenilla-Gaite
Journal:  Infect Prev Pract       Date:  2020-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.